(Q42275440)
Statements
1 reference
Assessment of pharmacokinetic interactions of the HCV NS5A replication complex inhibitor daclatasvir with antiretroviral agents: ritonavir-boosted atazanavir, efavirenz and tenofovir (English)
1 reference
Marc Bifano
1 reference
Carey Hwang
1 reference
Berend Oosterhuis
1 reference
Jan Hartstra
1 reference
Dennis Grasela
1 reference
Renger Tiessen
1 reference
Maria Velinova-Donga
1 reference
Hamza Kandoussi
1 reference
Heather Sevinsky
1 reference
Richard Bertz
1 reference
20 August 2013
1 reference
1 reference
Identifiers
1 reference